- •(Chronic) non-communicable diseases (NCD) are the main reason for disability and mortality in Western countries.
- •The most common NCD comprise cardiovascular, pulmonary and musculoskeletal diseases, type 2 diabetes mellitus, dementia and cancer.
- •(Online) NCD risk calculators are used for NCD screening and developing an individual health prevention and promotion strategy.
- •The review provides an overview of validated online available risk calculators.
- •Part (I) focusses on the NCD breast cancer, colorectal cancer, lung cancer and osteoporosis.
- •Part (II) will cover the NCD myocardial infarction, stroke, diabetes mellitus type 2 and dementia.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- World Health Organization, Noncommunicable diseases progress monitor, 2017.2017 (Accessed 16 March 2020)
Noncommunicable diseases, (n.d.). https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases. (Accessed 16 March 2020).
- The importance of preventive health care in post-menopausal women.Maturitas. 2005; 52: 53-60https://doi.org/10.1016/j.maturitas.2005.06.013
Breast Cancer Risk Assessment Tool, (n.d.). https://bcrisktool.cancer.gov/. (Accessed 16 March 2020).
BOADICEA Web Application, Cent. Cancer Genet. Epidemiol. (n.d.). https://ccge.medschl.cam.ac.uk/boadicea/boadicea-web-application/. (Accessed 16 March 2020).
Cuzick-Tyrer Model, (n.d.). http://www.ems-trials.org/riskevaluator/. (Accessed 16 March 2020).
BCSC Breast Cancer Risk Calculator, (n.d.). https://tools.bcsc-scc.org/BC5yearRisk/calculator.htm. (Accessed 9 April 2020).
Radiology Ltd Claus Model Calculator, (n.d.). http://young-ridge-2035.herokuapp.com/. (Accessed 16 March 2020).
Hereditary Cancer Quiz, (n.d.). https://www.hereditarycancerquiz.com/. (Accessed 17 March 2020).
Penn II Model, (n.d.). https://pennmodel2.pmacs.upenn.edu/penn2/. (Accessed 17 March 2020).
P. MacCallum, iPrevent Cancer Risk Assessment Tool, (n.d.). https://www.petermac.org/iprevent.
C. Australia, Cancer Australia website, (n.d.). https://canceraustralia.gov.au/clinical-best-practice/gynaecological-cancers/fra-boc/evaluate. (Accessed 16 March 2020).
GeneType, (n.d.). https://genetype.com/. (Accessed 16 March 2020).
Cancer, (n.d.). https://www.who.int/news-room/fact-sheets/detail/cancer. (Accessed 17 March 2020).
- Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.Ann. Intern. Med. 2014; 160: 311https://doi.org/10.7326/M13-2316
MyLungRisk, (n.d.). https://secure2.utlnet.co.uk/mylungrisk/about.aspx. (Accessed 16 March 2020).
Lung Cancer Screening Decision Tool | Memorial Sloan Kettering Cancer Center, (n.d.). http://nomograms.mskcc.org/Lung/Screening.aspx. (Accessed 17 March 2020).
Department of Epidemiology, MD Anderson Cancer Cent. (n.d.). http://www3.mdanderson.org/depts/epidemiology/spitzLCtool/controller.cfc?method=getSubjectData. (Accessed 17 March 2020).
Lung Cancer Risk Assessment Tool, (n.d.). https://www.aats.org/aatsimis/AATSWeb/Resources/Lung_Cancer_Screening/AATSWeb/Association/About/Resources/Lung_Cancer_Risk_Assessment_Tool.aspx?hkey=29f118a8-d7a6-4bcd-a9b3-7e85484881b8. (Accessed 17 March 2020).
B. University, Lung Cancer Risk Calculators, Brock Univ. 2014 (2013). http://brocku.ca./lung-cancer-risk-calculator. (Accessed 17 March 2020).
HUNT Lung Cancer Model Risk Calculator | Mens X Machina, (n.d.). http://mensxmachina.org/en/hunt-ntnu-lung-cancer-risk-calculator/. (Accessed 17 March 2020).
Lung Cancer Risk Assessment Tool (RNOT and LCDRAT), (n.d.). https://analysistools.nci.nih.gov/lungCancerRiskAssessment/#/. (Accessed 3 April 2020).
Lung Cancer Ontario, MyCancerIQ, (n.d.). https://www.mycanceriq.ca/Cancers/Lung.
Colorectal cancer, (2020). http://www.euro.who.int/en/health-topics/noncommunicable-diseases/cancer/news/news/2012/2/early-detection-of-common-cancers/colorectal-cancer (Accessed 17 March 2020).
Colorectal Cancer Risk Assessment Tool, (n.d.). https://www.cancer.gov/colorectalcancerrisk/ (Accessed 18 March 2020).
CRC-Pro, (n.d.). https://riskcalc.org/ColorectalCancer/.
Premm-Model Colorectal Cancer, (n.d.). http://premm.dfci.harvard.edu/.
Risikotest | Darmkrebs.de, (n.d.). https://www.darmkrebs.de/risikotest. (Accessed 17 March 2020).
Fragebogen Selbsttest | Stiftung LebensBlicke, (n.d.). https://www.lebensblicke.de/darmkrebs/selbsttest/. (Accessed 17 March 2020).
My CancerIQ, My CancerIQ. (n.d.). https://www.mycanceriq.ca/Cancers/Colorectal.
Osteoporosis.pdf, (n.d.). https://www.who.int/chp/topics/Osteoporosis.pdf. (Accessed 18 March 2020).
- Disability-adjusted-life-years losses in postmenopausal women with osteoporosis: a burden of illness study.BMC Public Health. 2015; : 1-10https://doi.org/10.1186/s12889-015-1684-7
FRAX, (n.d.). https://www.sheffield.ac.uk/FRAX/. (Accessed 18 March 2020).
Fracture Risk Score (FRISK) | Medicalalgorithms.com, (n.d.). http://medicalalgorithms.com//fracture-risk-frisk-score-of-henry-et-al. (Accessed 18 March 2020).
Garvan Fracture Risk Calculator, (n.d.). https://www.garvan.org.au/promotions/bone-fracture-risk/calculator/. (Accessed 18 March 2020).
FORE 10-Year Fracture Risk Calculator for Health Care Professionals, (n.d.). https://riskcalculator.fore.org/default.aspx. (Accessed 18 March 2020).
QFracture-2016, (n.d.). https://qfracture.org/index.php. (Accessed 18 March 2020).
Osteoporosis Risk SCORE Calculator, (n.d.). https://reference.medscape.com/calculator/osteoporosis-risk-score. (Accessed 18 March 2020).
TOP, (n.d.). http://www.osteorheuma.ch/top/index.aspx. (Accessed 18 March 2020).
Osteoporose-Risiko-Test - ‘Osteoswiss,’ (n.d.). https://www.osteoswiss.ch/index.php/de/links?id=156. (Accessed 18 March 2020).
Osteoporoserisiko - Rheumaliga Schweiz, (n.d.). https://www.rheumaliga.ch/osteoporoserisiko. (Accessed 18 March 2020).
IOF Risk check | International Osteoporosis Foundation, (n.d.). https://www.iofbonehealth.org/iof-one-minute-osteoporosis-risk-test. (Accessed 18 March 2020).
J.M.G. Wilson, G. Jungner, Principles and Practice of Screening for Disease, (n.d.) 168.
- A Life Course Approach to Healthy Ageing.Oxford University Press, Oxford2014
- A model of care for healthy menopause and ageing: EMAS position statement.Maturitas. 2016; 92: 1-6https://doi.org/10.1016/j.maturitas.2016.06.018
- Awareness, use and applicability of online risk calculators for non-communicable diseases—a cross-sectional study.Maturitas. 2018; 113: 1-6https://doi.org/10.1016/j.maturitas.2018.03.015
- Validation studies for models projecting the risk of invasive and total breast cancer incidence.J. Natl. Cancer Inst. 1999; 91: 1541-1548https://doi.org/10.1093/jnci/91.18.1541
- Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.J. Natl. Cancer Inst. 2001; 93: 358-366https://doi.org/10.1093/jnci/93.5.358
- Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics.J. Med. Genet. 2008; 45: 425-431https://doi.org/10.1136/jmg.2007.056556
- Long-term accuracy of breast cancer risk assessment combining classic risk factors and breast density.JAMA Oncol. 2018; 4e180174https://doi.org/10.1001/jamaoncol.2018.0174
- Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model.Ann. Intern. Med. 2008; 148: 337https://doi.org/10.7326/0003-4819-148-5-200803040-00004
- Breast density and benign breast disease: risk assessment to identify women at high risk of breast cancer.J. Clin. Oncol. 2015; 33: 3137-3143https://doi.org/10.1200/JCO.2015.60.8869
E.B. Claus, N. Risch, Genetic Analysis of Breast Cancer in the Cancer and Steroid Hormone Study, (n.d.) 11.
- Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.J. Clin. Oncol. 2002; 20: 1480-1490https://doi.org/10.1200/JCO.2002.20.6.1480
- Validation of three BRCA1/2 mutation-carrier probability models Myriad, BRCAPRO and BOADICEA in a population-based series of 183 German families.Fam. Cancer. 2012; 11: 181-188https://doi.org/10.1007/s10689-011-9498-y
- Selecting a BRCA risk assessment model for use in a familial cancer clinic.BMC Med. Genet. 2008; 9: 116https://doi.org/10.1186/1471-2350-9-116
- Accuracy of risk estimates from the iPrevent breast cancer risk assessment and management tool.JNCI Cancer Spectr. 2019; 3: 1-9https://doi.org/10.1093/jncics/pkz066
- NIH public access - predictive accuracy of the Liverpool lung project risk model for stratifying patients forcomputed tomography screening for lung cancer.Bone. 2013; 23: 1-7https://doi.org/10.1038/jid.2014.371
- Validation of a model of lung cancer risk prediction among smokers.J. Natl. Cancer Inst. 2006; 98: 637-640https://doi.org/10.1093/jnci/djj163
- Benchmarking lung cancer mortality rates in current and former smokers.Chest. 2004; 126: 1742-1749https://doi.org/10.1378/chest.126.6.1742
- A risk model for prediction of lung cancer.J. Natl. Cancer Inst. 2007; 99: 715-726https://doi.org/10.1093/jnci/djk153
- Selecting high-risk individuals for lung cancer screening: a prospective evaluation of existing risk models and eligibility criteria in the German EPIC cohort.Cancer Prev. Res. (Phila. Pa.). 2015; 8: 777-785https://doi.org/10.1158/1940-6207.CAPR-14-0424
- A risk model for lung cancer incidence.Cancer Prev. Res. (Phila. Pa.). 2012; 5: 834-846https://doi.org/10.1158/1940-6207.CAPR-11-0237
- Selection criteria for lung-cancer screening.N. Engl. J. Med. 2013; 368: 728-736https://doi.org/10.1056/NEJMoa1211776
- Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts.PLoS Med. 2014; 11e1001764https://doi.org/10.1371/journal.pmed.1001764
- A validated clinical risk prediction model for lung cancer in smokers of all ages and exposure types: a HUNT study.EBioMedicine. 2018; 31: 36-46https://doi.org/10.1016/j.ebiom.2018.03.027
- HHS public access - implication of 9 risk prediction models for selectin ever-smokers for CT lung-cancer screening.Physiol. Behav. 2017; 176: 139-148https://doi.org/10.1016/j.physbeh.2017.03.040
- Validation of a colorectal cancer risk prediction model among white patients age 50 years and older.J. Clin. Oncol. 2009; 27https://doi.org/10.1200/JCO.2008.17.4813
- ColoRectal cancer predicted risk online (CRC-PRO) calculator using data from the multi-ethnic cohort study.J. Am. Board Fam. Med. 2014; 27: 42-55https://doi.org/10.3122/jabfm.2014.01.130040
- Development and validation of the PREMM5 model for comprehensive risk assessment of lynch syndrome.J. Clin. Oncol. 2017; 35: 2165-2172https://doi.org/10.1200/JCO.2016.69.6120
- FRAX® assessment of osteoporotic fracture probability in Switzerland.Osteoporos. Int. 2010; 21: 381-389https://doi.org/10.1007/s00198-009-0975-1
- Prediction of absolute risk of fragility fracture at 10 years in a Spanish population: validation of the WHO FRAX™ tool in Spain.BMC Musculoskelet. Disord. 2011; 12: 1-9https://doi.org/10.1186/1471-2474-12-30
- Fracture risk (FRISK) score: geelong osteoporosis study.Radiology. 2006; 241: 190-196https://doi.org/10.1148/radiol.2411051290
- Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks.Osteoporos. Int. 2008; : 1431-1444https://doi.org/10.1007/s00198-008-0588-0
- External validation of the garvan nomograms for predicting absolute fracture risk: the tromsø study.PLoS One. 2014; 9e107695https://doi.org/10.1371/journal.pone.0107695
- Fracture risk tool validation in an integrated healthcare delivery system.Am. J. Manag. Care. 2011; 17: 7
- Validation of FRC, a fracture risk assessment tool, in a cohort of older men: the osteoporotic fractures in men (MrOS) study.J. Clin. Densitom. 2012; 15: 334-342https://doi.org/10.1016/j.jocd.2012.01.011
- Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study.BMJ. 2012; 344 (e3427–e3427)https://doi.org/10.1136/bmj.e3427
- Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores.BMJ. 2011; 342 (d3651–d3651)https://doi.org/10.1136/bmj.d3651
- Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density.Am. J. Manag. Care. 1998; 4: 37-48